FATE THERAPEUTICS INC
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $21.5M | $85.3M | $40.6M |
| Jun 2017 | $18.7M | $74.0M | $31.1M |
| Sep 2017 | $26.9M | $72.7M | $43.2M |
| Dec 2017 | $28.1M | $105.3M | $89.0M |
| Mar 2018 | $28.4M | $93.4M | $32.9M |
| Jun 2018 | $31.3M | $83.2M | $36.2M |
| Sep 2018 | $46.0M | $220.0M | $183.2M |
| Dec 2018 | $52.6M | $213.0M | $190.5M |
| Mar 2019 | $75.0M | $220.9M | $183.0M |
| Jun 2019 | $72.4M | $199.9M | $71.4M |
| Sep 2019 | $72.2M | $340.2M | $249.6M |
| Dec 2019 | $57.5M | $302.3M | $99.8M |
| Mar 2020 | $102.7M | $321.9M | $83.4M |
| Jun 2020 | $179.5M | $653.6M | $433.1M |
| Sep 2020 | $202.1M | $626.4M | $349.1M |
| Dec 2020 | $238.0M | $622.5M | $167.3M |
| Mar 2021 | $255.9M | $1.05B | $106.4M |
| Jun 2021 | $263.6M | $1.02B | $76.7M |
| Sep 2021 | $254.2M | $984.6M | $129.2M |
| Dec 2021 | $242.6M | $921.5M | $133.6M |
| Mar 2022 | $225.0M | $858.4M | $64.7M |
| Jun 2022 | $226.6M | $807.1M | $55.3M |
| Sep 2022 | $231.3M | $749.3M | $82.1M |
| Dec 2022 | $221.6M | $705.6M | $61.3M |
| Mar 2023 | $152.9M | $630.3M | $42.0M |
| Jun 2023 | $147.0M | $584.8M | $46.8M |
| Sep 2023 | $141.0M | $543.8M | $33.3M |
| Dec 2023 | $137.8M | $506.2M | $41.9M |
| Mar 2024 | $143.8M | $569.9M | $121.3M |
| Jun 2024 | $131.8M | $528.8M | $36.9M |
| Sep 2024 | $132.6M | $495.0M | $37.9M |
| Dec 2024 | $122.0M | $440.7M | $36.1M |
| Mar 2025 | $110.3M | $398.7M | $44.9M |
| Jun 2025 | $110.3M | $371.6M | $41.2M |
| Sep 2025 | $109.6M | $343.7M | $40.6M |
| Dec 2025 | $111.8M | $318.9M | $46.6M |
| Mar 2026 | $105.2M | $284.9M | $39.6M |
| Jun 2026 | $106.7M | $260.1M | $32.4M |